The tumor-promoting impact of EIF3B was found to be mediated through PCNA, and the inhibition of PCNA not only suppressed the development of cholangiocarcinoma but also reversed the promotional effects induced by EIF3B overexpression. This evidence concerns the gene EIF3B and cholangiocarcinoma.